Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro

References

• Bahar MA, Setiawan D, Hak E, Wilffert B. 2017. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. Pharmacogenomics. 18(7):701–739. doi: 10.2217/pgs-2017-0194.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen H, Lu Y, Han L, Wang S, Liu M, Li X, Zhao J, Lu C, Li S. 2020. Decoding active components in a formulation of multiple herbs for treatment of psoriasis based on three cell lines fishing and liquid chromatography-mass spectrometry analysis. J Pharm Biomed Anal. 186:113331. doi: 10.1016/j.jpba.2020.113331.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang L, Zhang P, Guo H, Zhang R, Li L, Li X. 2023. Prediction of cytochrome P450 inhibition using a deep learning approach and substructure pattern recognition. J Chem Inf Model. Published online October 21, 2023. doi: 10.1021/acs.jcim.3c01396.
   Web of Science ®Google Scholar
• Chung WK, Hwang I, Kim B, Jung J, Yu KS, Jang IJ, Oh J. 2023. Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clin Transl Sci. 16(3):512–523. doi: 10.1111/cts.13466.
   PubMed Web of Science ®Google Scholar
• Fu C, Wu Y, Liu S, Luo C, Lu Y, Liu M, Wang L, Zhang Y, Liu X. 2022. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 289:115021. doi: 10.1016/j.jep.2022.115021.
   PubMed Web of Science ®Google Scholar
• Fujiyama K, Hino T, Nagano S. 2022. Diverse reactions catalyzed by cytochrome P450 and biosynthesis of steroid hormone. Biophys Physicobiol. 19:e190021.
   PubMed Web of Science ®Google Scholar
• Herrera-Acevedo C, Flores-Gaspar A, Scotti L, Mendonça-Junior FJB, Scotti MT, Coy-Barrera E. 2021. Identification of kaurane-type diterpenes as inhibitors of leishmania pteridine reductase I. Molecules. 26(11):3076. doi: 10.3390/molecules26113076.
   PubMed Web of Science ®Google Scholar
• Hong E, Carmanov E, Shi A, Chung PS, Rao AP, Forrester K, Beringer PM. 2023. Application of physiologically based pharmacokinetic modeling to predict drug-drug interactions between elexacaftor/tezacaftor/ivacaftor and tacrolimus in lung transplant recipients. Pharmaceutics. 15(5):1438. doi: 10.3390/pharmaceutics15051438.
   PubMed Web of Science ®Google Scholar
• Kamble SH, Sharma A, King TI, Berthold EC, León F, Meyer PKL, Kanumuri SRR, McMahon LR, McCurdy CR, Avery BA. 2020. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids. Toxicol Lett. 319:148–154. doi: 10.1016/j.toxlet.2019.11.005.
   PubMed Web of Science ®Google Scholar
• Li D, Yu T, Hu J, Wu J, Feng S, Xu Q, Zhu H, Zhang X, Zhang Y, Zhou B, et al. 2021. Downregulation of CYP39A1 serves as a novel biomarker in hepatocellular carcinoma with worse clinical outcome. Oxid Med Cell Longev. 2021:5175581–18. doi: 10.1155/2021/5175581.
   PubMed Web of Science ®Google Scholar
• Li Y, Qin J, Wu H, Xu Y, Zhang L, Su K, Cui Y, Wang H. 2020. In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes. Pharm Biol. 58(1):695–700. doi: 10.1080/13880209.2020.1787468.
   PubMed Web of Science ®Google Scholar
• Li ZF, Yang YQ, Xie DF, Zhu LF, Zhang ZG, Lin WX. 2012. Identification of autotoxic compounds in fibrous roots of Rehmannia (Rehmannia glutinosa Libosch.). PLoS One. 7(1):e28806. doi: 10.1371/journal.pone.0028806.
   PubMed Web of Science ®Google Scholar
• Lim SYM, Al Bishtawi B, Lim W. 2023. Role of cytochrome P450 2C9 in COVID-19 treatment: current status and future directions. Eur J Drug Metab Pharmacokinet. 48(3):221–240. doi: 10.1007/s13318-023-00826-8.
   PubMed Web of Science ®Google Scholar
• Liu C, Ma R, Wang L, Zhu R, Liu H, Guo Y, Zhao B, Zhao S, Tang J, Li Y, et al. 2017. Rehmanniae Radix in osteoporosis: a review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J Ethnopharmacol. 198:351–362. doi: 10.1016/j.jep.2017.01.021.
   PubMed Web of Science ®Google Scholar
• Liu N, Chen P, Du X, Sun J, Han S. 2021. In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1. BMC Complement Med Ther. 21(1):218. doi: 10.1186/s12906-021-03397-w.
   PubMedGoogle Scholar
• Orr ST, Ripp SL, Ballard TE, Henderson JL, Scott DO, Obach RS, Sun H, Kalgutkar AS. 2012. Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks. J Med Chem. 55(11):4896–4933. doi: 10.1021/jm300065h.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhang G, Mackie B, Yang S, Wang J, Shan L. 2016. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes. J Chromatogr B Analyt Technol Biomed Life Sci. 1029-1030:145–156. doi: 10.1016/j.jchromb.2016.06.031.
   PubMed Web of Science ®Google Scholar
• Sun M, Shen X, Ma Y. 2019. Rehmannioside A attenuates cognitive deficits in rats with vascular dementia (VD) through suppressing oxidative stress, inflammation and apoptosis. Biomed Pharmacother. 120:109492. doi: 10.1016/j.biopha.2019.109492.
   PubMed Web of Science ®Google Scholar
• Tang H, Hosein A, Mattioli-Belmonte M. 2021. Traditional Chinese Medicine and orthopedic biomaterials: host of opportunities from herbal extracts. Mater Sci Eng C Mater Biol Appl. 120:111760. doi: 10.1016/j.msec.2020.111760.
   PubMed Web of Science ®Google Scholar
• Wang H, Xia B, Lin M, Wang Y, Sun B, Li Y. 2020a. Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes. Pharm Biol. 58:1150–1155.
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang W, Zhou J, Xue X, Yin C. 2020b. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes. Pharm Biol. 58(1):1064–1069. doi: 10.1080/13880209.2020.1835996.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang X, Wang Z, Lv X, Yin H, Li W, Li W, Jiang L, Liu Y. 2022. Potential herb-drug interaction risk of thymoquinone and phenytoin. Chem Biol Interact. 353:109801. doi: 10.1016/j.cbi.2022.109801.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou K, Liang Z, Zhang H, Song Y, Yang X, Xiang D, Xie Q. 2023. In vitro investigation on the effect of dendrobine on the activity of cytochrome P450 enzymes. Planta Med. 89(1):72–78. doi: 10.1055/a-1806-2935.
   PubMedGoogle Scholar
• Xiao S, Wang C, Yang Q, Xu H, Lu J, Xu K. 2021. Rea regulates microglial polarization and attenuates neuronal apoptosis via inhibition of the NF-kappaB and MAPK signalings for spinal cord injury repair. J Cell Mol Med. 25(3):1371–1382. doi: 10.1111/jcmm.16220.
   PubMed Web of Science ®Google Scholar
• Xu S, Zhang F, Chen D, Su K, Zhang L, Jiang R. 2020. In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes. Pharm Biol. 58(1):308–313. doi: 10.1080/13880209.2020.1747500.
   PubMed Web of Science ®Google Scholar
• Yuan LL, Cao CY. 2023. Rehmannioside A inhibits TRAF6/MAPK pathway and improves psoriasis by interfering with the interaction of HaCaT Cells with IL-17A. Clin Cosmet Investig Dermatol. 16:2585–2596. doi: 10.2147/CCID.S430621.
   PubMed Web of Science ®Google Scholar
• Yuan M, Yuan B. 2022. Antidepressant-like effects of Rehmannioside A on rats induced by chronic unpredictable mild stress through inhibition of endoplasmic reticulum stress and apoptosis of hippocampus. J Chem Neuroanat. 125:102157. doi: 10.1016/j.jchemneu.2022.102157.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. 2008. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 392(6):1093–1108. doi: 10.1007/s00216-008-2291-6.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Wang A, Yu Y, Chen J, Xu X, Nie J, Lin J. 2023. Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes. Front Pharmacol. 14:1199548. doi: 10.3389/fphar.2023.1199548.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu MX, Li HM, Sun J, Huang LQ, Yuan Y. 2023. Potential benefits of Rehmanniae Radix after ancient rice-steaming process in promotion of antioxidant activity in rats’ health. Food Sci Nutr. 11(9):5532–5542. doi: 10.1002/fsn3.3509.
   PubMed Web of Science ®Google Scholar
• Zhi J, Li Y, Zhang Z, Yang C, Geng X, Zhang M, Li X, Zuo X, Li M, Huang Y, et al. 2018. Molecular regulation of catalpol and acteoside accumulation in radial striation and non-radial striation of rehmannia glutinosa tuberous root. Int J Mol Sci. 19(12):3751–3771.
   PubMed Web of Science ®Google Scholar